Phenomenological Research Awards

  📘 Emotional Intelligence in Teaching: A 21st- Century Research Evolution 📊 In the fast- evolving landscape of education, one psychological factor stands out as a game- changer— Emotional Intelligence ( EI) . 🌟 For educators, this isn’t just a buzzword; it’s a key to unlocking effective teaching, strong classroom management, and sustained professional well- being. As we step deeper into the 21st century, understanding how Teacher Emotional Intelligence ( TEI) has been studied and developed becomes crucial for educators, researchers, and policy- makers alike. Our latest bibliometric analysis sheds light on the dynamic growth and transformation of TEI research from 2000 to 2023. 📅 Using data from 258 academic publications indexed in the Web of Science ( WoS) core databases, this study maps out the trajectory, trends, and transformative patterns in TEI scholarship across the globe. 🌐 📈 Two Decades, Two Phases: TEI Research Timeline Our findings reveal that the study of TEI...

  🌟 Celebrating Excellence in Education: Apply for the Outstanding Educator Award 🏆 Are you a passionate researcher or technician 👩‍🔬👨‍🏫 who goes beyond the conventional classroom to ignite minds, inspire curiosity, and shape future leaders? Do you integrate innovation, research, and mentorship into your teaching? If yes, then the Outstanding Educator Award is calling you! 📣 This prestigious recognition is more than just an award— it's a tribute to your unwavering commitment to transforming education and impacting lives. 🌍📚 🎓 About the Outstanding Educator Award The Outstanding Educator Award honors exceptional individuals in academia who have demonstrated: Excellence in teaching 📖 Innovation in pedagogy 💡 Profound impact on students and academic communities 👩‍🎓👨‍🎓 Whether you’re in a classroom, laboratory, or remote field station, your dedication to advancing knowledge and fostering growth deserves global recognition— and this award is designed fo...

  🔬 Luminal Subtypes & Extended Anastrozole: Insights from the DATA Trial Breast cancer remains a complex and heterogeneous disease, especially in hormone receptor- positive ( HR+) subtypes, where treatment decisions are highly nuanced. One area gaining increased attention is the role of luminal- like subtypes — luminal A- like and luminal B- like — in predicting outcomes and guiding therapy. A recent in- depth analysis of the DATA trial ( NCT00301457) offers compelling evidence on the prognostic and predictive value of these subtypes in HR+ breast cancer. Let’s break it down for clinical researchers, oncologists, and lab technicians. 🧪🧬 🧫 Study Overview The DATA trial was a phase III clinical study that evaluated the efficacy of extended anastrozole therapy — 6 years versus 3 years— following 2– 3 years of tamoxifen in postmenopausal women with early- stage HR+ breast cancer . For this substudy, 788 patients with available formalin- fixed paraffin- embedded ( FFPE...